Prazosin Hydrochloride Capsules, USP, 1 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-1101-01
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Prazosin Hydrochloride Capsules, USP, 1 mg in 100-count bottles manufactured by Mylan Pharma due to temperature abuse during storage, which violates good manufacturing practice (cGMP) requirements. The recall affects eight bottles totaling 800 tablets distributed nationwide across the United States. Because McKesson cannot identify which specific lot number was received by individual customers, the company provided distribution dates to customers to help them determine if their product may have been affected.
The source document does not specify a remedy or what affected consumers should do in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 8 bottles/100 tablets each Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.